{"basic_info": {"ticker": "300142", "exchange": "XSHE", "bloomberg_ticker": "300142 CH Equity", "name": "WALVAX BIOTECHNOLOGY CO-A", "industry": "Biotechnology", "name_chinese_simplified": "沃森生物", "period": "2020", "market_value": 59098775552, "total_income": 2939021219, "ccy": "人民币元", "shariah_compliance_summary": "compliant"}, "business_activity_screening": {"summary": [{"shariah_compliance": "compliant", "income": 2927398169, "business_income_over_total_income": 0.9960452650273975}, {"shariah_compliance": "unknown", "income": 11623045, "business_income_over_total_income": 0.003954733271355806}], "details": [{"business_activity_cn": "13价肺炎球菌多糖结合疫苗", "business_activity_en": "13-valent pneumococcal polysaccharide conjugate vaccine", "income": 1658457453, "business_income_over_total_income": 0.5642890368665964, "shariah_compliance": "compliant"}, {"business_activity_cn": "23价肺炎球菌多糖疫苗", "business_activity_en": "23-valent pneumococcal polysaccharide vaccine", "income": 688020384, "business_income_over_total_income": 0.23409847453707683, "shariah_compliance": "compliant"}, {"business_activity_cn": "b型流感嗜血杆菌结合疫苗", "business_activity_en": "Haemophilus influenzae type b conjugate vaccine", "income": 202421567, "business_income_over_total_income": 0.06887380250656162, "shariah_compliance": "compliant"}, {"business_activity_cn": "冻干AC疫苗群脑膜炎球菌多糖结合疫苗", "business_activity_en": "AC freeze-dried vaccine meningococcal polysaccharide conjugate vaccine", "income": 116851363, "business_income_over_total_income": 0.039758597945665254, "shariah_compliance": "compliant"}, {"business_activity_cn": "A群C群脑膜炎球菌多糖疫苗", "business_activity_en": "A group C meningococcal polysaccharide vaccine", "income": 96597992, "business_income_over_total_income": 0.032867402036950044, "shariah_compliance": "compliant"}, {"business_activity_cn": "ACYW135群脑膜炎球菌多糖疫苗", "business_activity_en": "ACYW135 meningococcal polysaccharide vaccine", "income": 91389284, "business_income_over_total_income": 0.03109514263088415, "shariah_compliance": "compliant"}, {"business_activity_cn": "吸附无细胞百白破联合疫苗", "business_activity_en": "Adsorbed acellular pertussis combination vaccine", "income": 40162819, "business_income_over_total_income": 0.013665372247181453, "shariah_compliance": "compliant"}, {"business_activity_cn": "中间产品收入", "business_activity_en": "Intermediate product revenue", "income": 32417133, "business_income_over_total_income": 0.011029907776926466, "shariah_compliance": "compliant"}, {"business_activity_cn": "技术服务", "business_activity_en": "Technical Services", "income": 1080174, "business_income_over_total_income": 0.00036752847955535636, "shariah_compliance": "compliant"}, {"business_activity_cn": "其他业务", "business_activity_en": "Other business", "income": 11623045, "business_income_over_total_income": 0.003954733271355806, "shariah_compliance": "unknown"}, {"business_activity_cn": "合计特别调整", "business_activity_en": "Total special adjustments", "income": 0, "business_income_over_total_income": 0.0, "shariah_compliance": "unknown"}]}, "financial_screening": [{"item": "Debt to Market Capitalization", "amount": 0.001598988622825452, "shariah_compliance": "compliant", "amount_over_market_value": 0.001598988622825452}]}